Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2018 Feb 8;57(4):235–244.e2. doi: 10.1016/j.jaac.2018.01.015

Figure 1.

Figure 1

Response trajectory in antidepressant-treated youth with generalized, separation and social anxiety disorders. Note: Standardized medication-placebo difference (“Mean Change”) was logarithmic in the best fitting model (A) and differed by antidepressant class (B) but not dose (C). Green and blue lines represent Selective Serotonin Norepinephrine Reuptake Inhibitors (SSNRIs) and Selective Serotonin Reuptake Inhibitors (SSRIs), respectively, while purple and orange lines denote high and low dose SSRI treatment, respectively. Dotted gray lines reflect the 95% confidence interval. Significant difference in variance posterior mean estimates (p<0.001) were observed between high (purple) and low (orange) dose SSRI treatment (D).